| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $103.8M | +21.1% |
| SG&A Expense | $47.3M | +1.6% |
| Operating Income | -$137.1M | -17.8% |
| Interest Expense | $13.2M | +167.8% |
| Pre-tax Income | -$84.0M | +35.2% |
| Net Income | -$84.0M | +35.2% |
| EPS (Basic) | -$1.49 | +48.1% |
| EPS (Diluted) | -$1.49 | +48.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $129.6M | +12.2% |
| Accounts Receivable | $10.1M | -52.5% |
| Current Assets | $159.6M | +3.4% |
| Total Assets | $326.7M | +2.7% |
| Current Liabilities | $67.1M | -18.3% |
| Total Liabilities | $188.6M | -6.0% |
| Stockholders' Equity | $138.2M | +17.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$105.4M | -44.1% |
| Capital Expenditures | $20.2M | -55.1% |
| Investing Cash Flow | $34.0M | +175.7% |
| Financing Cash Flow | $84.0M | -11.7% |
| Free Cash Flow | -$125.5M | -6.3% |